Abstracts (HTML) List of Authors

Jafoui, S

Hepatocyte KLF6 regulates autophagy in a p53 dependent manner
Die Inhibition von Polo-like Kinasen resultiert in Degradation von Bcl-2 und wirkt dadurch pro-apoptotisch in Cholangiocarzinom Zellen

Jahn, D

The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma
Vitamin D3 improves liver histology and hepatic gene expression in a murine obesity/NASH model independently of intestinal Fgf15 induction

James, E

The impact of ERAP1 polymorphisms on virus-specific CD8+ T cell responses in an HLA*B27+ patient with acute hepatitis C virus infection

James, LP

Hsp72 overexpression protects from liver injury and hepatocellular death via attenuation of oxidative stress and JNK-signaling

Janczyk, W

Biopsy-based analysis of the prosteatotic TM6SF2 p.E167K and PNPLA3 p.I148 M gene variants as potential modifiers of Wilson disease

Janicot, M

Anti-fibrotic and anti-inflammatory consequences of TGF-β2 silencing in biliary liver disease

Janik, MK

Shear wave elastography of the liver and spleen in patients with autoimmune hepatitis and its variants – A single centre study

Jansen, C

Combined Photodynamic Therapy with Systemic Chemotherapy Compared to Chemotherapy or Photodynamic Therapy Alone in Patients with Non-Resectable Extrahepatic Cholangiocarcinoma: a Retrospective Study

Jöhrens, K

A cholesterol-containing modified western diet inducing steatohepatitis (NASH) with insulin resistance in wildtype B6 mice

Jones, D

Anti-fibrotic and anti-inflammatory consequences of TGF-β2 silencing in biliary liver disease

Jung, F

ERCP in patients with PSC and cirrhosis is not associated with an increased rate of complications

Jung, MC

First time use of PRISM, an easy to use and suitable tool to characterize burden of disease, in patients suffering from chronic Hepatitis C: Results from the German observational study LIFE-C

Jüngst, C

NOD2 genetic variants confer risk for secondary sclerosing cholangitis in critically ill patients